Hq Spclt Pharma Drug Patent Portfolio
Hq Spclt Pharma owns 4 orange book drugs protected by 10 US patents Given below is the list of Hq Spclt Pharma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10130646 | Calcium gluconate solutions in flexible containers | 25 Jul, 2037 | Active |
| US10342813 | Calcium gluconate solutions in flexible containers | 25 Jul, 2037 | Active |
| US9649296 | Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container | 20 Apr, 2036 | Active |
| US9717796 | Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container | 20 Apr, 2036 | Active |
| US8829054 | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container | 15 Mar, 2033 | Active |
| US8835505 | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container | 15 Mar, 2033 | Active |
| US6310094 | Ready-to-use esmolol solution | 12 Jul, 2021 | Expired |
| US6528540 | Esmolol formulation | 12 Jul, 2021 | Expired |
| US6310094 | Ready-to-use esmolol solution | 12 Jan, 2021 | Expired |
| US6528540 | Esmolol formulation | 12 Jan, 2021 | Expired |
Latest Legal Activities on Hq Spclt Pharma's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Hq Spclt Pharma.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 28 Dec, 2022 | US10342813 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 04 May, 2022 | US10130646 (Litigated) |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 28 Apr, 2021 | US10342813 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 09 Feb, 2021 | US10130646 (Litigated) |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 20 Jan, 2021 | US9717796 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 09 Oct, 2020 | US9717796 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 24 Sep, 2020 | US9649296 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 09 Jul, 2019 | US10342813 |
|
Recordation of Patent Grant Mailed
Critical
| 09 Jul, 2019 | US10342813 |
|
Email Notification
Critical
| 20 Jun, 2019 | US10342813 |
|
Issue Notification Mailed
Critical
| 19 Jun, 2019 | US10342813 |
| Dispatch to FDC | 12 Jun, 2019 | US10342813 |
|
Application Is Considered Ready for Issue
Critical
| 31 May, 2019 | US10342813 |
|
Issue Fee Payment Verified
Critical
| 30 May, 2019 | US10342813 |
|
Issue Fee Payment Received
Critical
| 30 May, 2019 | US10342813 |
Hq Spclt Pharma's Drug Patent Litigations
Hq Spclt Pharma's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Nov 19, 2015, against patent number US6528540. The petitioner Mylan Pharmaceuticals Inc., challenged the validity of this patent, with Baxter International Inc. as the respondent. Click below to track the latest information on how companies are challenging Hq Spclt Pharma's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US6310094 | November, 2015 |
Terminated-Denied
(27 Apr, 2016)
| Baxter International Inc. | Mylan Pharmaceuticals Inc. |
| US6528540 | November, 2015 |
Terminated-Denied
(27 Apr, 2016)
| Baxter International Inc. | Mylan Pharmaceuticals Inc. |
Hq Spclt Pharma's Family Patents
Hq Spclt Pharma Drug List
Given below is the complete list of Hq Spclt Pharma's drugs and the patents protecting them.
1. Calcium Gluconate In Sodium Chloride
Calcium Gluconate In Sodium Chloride is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10130646 | Calcium gluconate solutions in flexible containers |
25 Jul, 2037
(12 years from now)
| Active |
| US10342813 | Calcium gluconate solutions in flexible containers |
25 Jul, 2037
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Calcium Gluconate In Sodium Chloride's drug page
2. Dexmedetomidine Hydrochloride
Dexmedetomidine Hydrochloride is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9649296 | Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container |
20 Apr, 2036
(11 years from now)
| Active |
| US9717796 | Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container |
20 Apr, 2036
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Dexmedetomidine Hydrochloride's drug page
3. Esmolol Hydrochloride Double Strength In Plastic Container
Esmolol Hydrochloride Double Strength In Plastic Container is protected by 6 patents, out of which 4 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8829054 | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
15 Mar, 2033
(8 years from now)
| Active |
| US8835505 | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
15 Mar, 2033
(8 years from now)
| Active |
| US6310094
(Pediatric)
| Ready-to-use esmolol solution |
12 Jul, 2021
(3 years ago)
| Expired |
| US6528540
(Pediatric)
| Esmolol formulation |
12 Jul, 2021
(3 years ago)
| Expired |
| US6310094 | Ready-to-use esmolol solution |
12 Jan, 2021
(3 years ago)
| Expired |
| US6528540 | Esmolol formulation |
12 Jan, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Esmolol Hydrochloride Double Strength In Plastic Container's drug page
4. Esmolol Hydrochloride In Plastic Container
Esmolol Hydrochloride In Plastic Container is protected by 6 patents, out of which 4 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8829054 | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
15 Mar, 2033
(8 years from now)
| Active |
| US8835505 | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
15 Mar, 2033
(8 years from now)
| Active |
| US6310094
(Pediatric)
| Ready-to-use esmolol solution |
12 Jul, 2021
(3 years ago)
| Expired |
| US6528540
(Pediatric)
| Esmolol formulation |
12 Jul, 2021
(3 years ago)
| Expired |
| US6310094 | Ready-to-use esmolol solution |
12 Jan, 2021
(3 years ago)
| Expired |
| US6528540 | Esmolol formulation |
12 Jan, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Esmolol Hydrochloride In Plastic Container's drug page